P1-IS-49 Hysteroscopy Examination in Women with Breast Cancer Receiving Tamoxifen
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人 日本産科婦人科学会の論文
- 2007-02-01
著者
-
Cheng Ya-Min
Department of Nursing & Department of Obstetrics and Gynecology, College of Medicine, National Cheng
-
Cheng Ya-min
Department Of Ob Gyn Institute Of Clinical Medicine College Of Medicine National Cheng Kung Universi
-
CHOU Cheng-Yang
Department of Nuclear Medicine, Medical College, National Cheng Kung University Medical Center
-
Chou Cheng-yang
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
-
Chou Cheng-yang
Department Of Ob Gyn Institute Of Clinical Medicine College Of Medicine National Cheng Kung Universi
関連論文
- IS-21 Health Beliefs of Taiwanese Women seeking HPV Vaccination(Group3 Oncology3,International Session)
- Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT
- IS-20 Volume-activated taurine transport in human cervical cells with different tumor potential
- IS-49 Loss of b type FGFR promote cell invasive ability- a possible role in cervical carcinogenesis(Group6 Oncology3,International Session)
- IS-11 GnRH agonist-induced DNA damage on uterine leiomyomas is indirectly through estrogen suppression
- IS-64 Antenatal Diagnosis of Alobar Holoprosencephaly by Two-dimensional and Three-dimensional Ultrasound
- IS-69 The Value of Preoperative Serum CA125 in Endometriosis Patient
- Novel method for preoperative prediction of Gonadotropin releasing hormone agonist (GnRH-a) treatment response in uterine leiomyoma by 3D power Doppler ultrasonography(Oncology 13)
- 6-29.Different tumor vascular pattern evaluated by 3D Power Doppler ultrasonography(Session 8 Reproduction 2)
- Serial follow up of uterine leiomyoma patient receiving GnRH-agonist with 3D power Doppler ultrasonography(Session15 Oncology7)
- Enhanced Polyadenosine Diphosphate-ribosylation of Smooth Muscle Cells in GnRH Agonist-Treated Uterine Leio-myoma(Session6 Oncology6)
- P-IS-17 Fibroblast growth factor receptor 1 (FGFR1) overexpression play a possible role in cervical carcinogenesis(Oncology 5,Group 92,International Session)
- P1-IS-49 Hysteroscopy Examination in Women with Breast Cancer Receiving Tamoxifen
- IS-33 The Expression of Circulating IGF System in Cervical Cancer and Ovarian Cancer : A Preliminary Result(Group5 Oncology5,International Session)
- IS-105 Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy(Group13 Oncology5,International Session)
- IS-72 Fas Ligand and Procaspase 3 Are Constitutively Expressed in Uterine Myometrium, Up-regulated in Leiomyoma and Down-regulated Following Gonadotropin Releasing Hormone Agonist Treatment
- Evidence of Human Papillomavirus Infection, Enhanced Phosphorylation of Retinoblastoma Protein and Decreased Apoptosis in Sarcomatoid Squamous Cell Carcinoma of Uterine Cervix(Oncology 8)
- ISP-3-5 The role of human papillomavirus (HPV) types 16 E6/E7 oncoproteins in fibroblast growth factor (FGF) 2 and 4 induced cervical epithelial-mesenchymal transition (EMT) and carcinogenesis(Group 3 Oncology 3,IS Poster,International Session)